EUVIMEDOpdag EUVIMED
Crossref

Utilidad de la aplicación de vancomicina tópica en la prevención de infección de sitio quirúrgico de la columna lumbosacra

F Revilla-Pacheco, L Rivera-May, S Manrique-Guzmán, T Herrada-Pineda, I Franco-Granillo Hoyo, AK Perez-Vazquez, MJ Wilches-Dávalos

Acta Ortopédica Mexicana · 2024

DOI: 10.35366/115075 ↗

At a glance

Journal article in Acta Ortopédica Mexicana, 2024. Written by F Revilla-Pacheco and 6 co-authors. Cited 2 times so far (Crossref); 55 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction: surgical site infections (SSI) remain a significant cause of morbidity and mortality and one of the most representative causes of nosocomial infections. The use of intrawound vancomycin in lumbar spine surgery is a potential prophylactic measure against SSI; however, evidence regarding its efficacy is contradictory. Our study was designed to research if intrawound vancomycin significantly prevents SSI in lumbar spine surgery. Material and methods: this is a randomized, double-blinded, controlled clinical trial; 233 patients who underwent lumbar spine surgery, were randomly assigned to a group in which intrawound vancomycin was instilled in the incision before closure (109), or to a control group (114). The main outcome is the presence of SSI; we determined its prevalence and searched for difference between groups for association between SSI and independent variables. Results: global SSI prevalence was 1.8%, in the experimental group was 0.9%, in the control group was 2.6%. There was no significant difference between these values, p = 0.622. The relative risk of SSI in the experimental group was 0.35 (95% CI 0.037-3.30), that of the control group was 2.87 (95% CI 0.30-27.16). The number needed to treat is 58.3. We did not find a significant association between the independent variables studied and the appearance of SSI. Conclusions: we did not find a significant difference in the prevalence of SSI between groups nor a significant association between SSI and independent variables.

Cite

APA

Revilla-Pacheco, F., Rivera-May, L., Manrique-Guzmán, S., Herrada-Pineda, T., Hoyo, I. F., Perez-Vazquez, A., & Wilches-Dávalos, M. (2024). Utilidad de la aplicación de vancomicina tópica en la prevención de infección de sitio quirúrgico de la columna lumbosacra. Acta Ortopédica Mexicana. https://doi.org/10.35366/115075

Vancouver

Revilla-Pacheco F, Rivera-May L, Manrique-Guzmán S, Herrada-Pineda T, Hoyo IF, Perez-Vazquez A, et al. Utilidad de la aplicación de vancomicina tópica en la prevención de infección de sitio quirúrgico de la columna lumbosacra. Acta Ortopédica Mexicana. 2024. doi:10.35366/115075

BibTeX
@article{RevillaPacheco2024,
  author = {Revilla-Pacheco, F and Rivera-May, L and Manrique-Guzmán, S and Herrada-Pineda, T and Hoyo, I Franco-Granillo and Perez-Vazquez, AK and Wilches-Dávalos, MJ},
  title = {Utilidad de la aplicación de vancomicina tópica en la prevención de infección de sitio quirúrgico de la columna lumbosacra},
  journal = {Acta Ortopédica Mexicana},
  year = {2024},
  doi = {10.35366/115075}
}
Start for free →